Punctal occlusion may reduce reactions without worsening symptoms
Steven Silverstein, MD
Advertisement
Silverstein is a founding partner of Silverstein Eye Centers, in Kansas City, Missouri. He is also an assistant professor of ophthalmology at the University of Missouri Kansas City Medical School, and clinical professor of ophthalmology at Kansas City University of Medicine and Biosciences.
Articles by Steven Silverstein, MD
As dexamethasone adds indications, a study confirms efficacy of punctal occlusion for allergic conjunctivitis.
Taking control of a practice’s future with investment, creative thinking
Advertisement
Latest Updated Articles
Four tips for growing a proactive practiceAugust 10th 2021
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes
2
First patient dosed in phase 3 pivotal cohort of LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis
3
ARPA-H funds tear-duct biosensor system for dry eye, systemic disease
4
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
5